Complete Filing Data
Tarsus Pharmaceuticals, Inc. reported Stockholders Equity of $343.43 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Tarsus Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$66.4M | -$115.6M | -$135.9M | -$62.1M | -$13.8M | -$26.8M | -$4.7M | -$1.3M |
| Research And Development Expense | $64.3M | $53.4M | $50.3M | $42.6M | $41.7M | $18.8M | $3.2M | |
| Operating Income Loss | -$71.0M | -$120.6M | -$143.2M | -$62.7M | -$12.2M | -$27.0M | -$4.3M | |
| Nonoperating Income Expense | $6.6M | $5.0M | $7.3M | $617.0K | -$1.6M | $188.0K | -$371.0K | |
| Comprehensive Income Net Of Tax | -$66.2M | -$115.4M | -$135.8M | -$62.2M | -$13.8M | -$26.8M | -$4.7M | |
| Other Nonoperating Income Expense | -$202.0K | -$206.0K | $274.0K | $86.0K | -$73.0K | $0.00 | ||
| Revenues | $451.4M | $183.0M | $17.4M | $25.8M | $57.0M | $0.00 | ||
| General And Administrative Expense | $44.9M | $25.4M | $8.2M | $1.1M | ||||
| Income Tax Expense Benefit | $2.1M | $0.00 | $0.00 | -$4.0K | $55.0K | $1.0K | $1.0K | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $202.0K | $181.0K | $72.0K | -$74.0K | $0.00 | |||
| Other Comprehensive Income Loss Net Of Tax | $202.0K | $181.0K | $72.0K | -$74.0K | ||||
| Amortization Of Intangible Assets | $961.0K | $540.0K | $133.0K | $0.00 | ||||
| Operating Expenses | $160.6M | $88.5M | $69.2M | $27.0M | $4.3M | |||
| Cost Of Goods And Services Sold |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$12.6M | -$20.3M | -$25.1M | -$23.4M | -$33.3M | -$35.7M | -$39.1M | -$31.4M | -$23.4M | -$22.5M | -$5.7M | -$20.2M | -$15.7M | $6.3M | $10.4M | -$10.1M | -$3.3M | -$2.0M | -$681.0K | -$831.0K | -$1.7M |
| Research And Development Expense | $16.3M | $15.6M | $14.4M | $12.1M | $12.3M | $12.1M | $12.1M | $12.5M | $12.4M | $10.9M | $9.6M | $12.1M | $10.2M | $7.2M | $16.3M | $8.0M | $1.7M | $1.5M | $399.0K | ||
| Operating Income Loss | -$14.5M | -$22.2M | -$26.3M | -$25.2M | -$33.3M | -$37.7M | -$40.9M | -$32.8M | -$25.0M | -$22.9M | -$5.2M | -$19.5M | -$15.7M | $7.3M | $10.7M | -$10.1M | -$3.3M | -$2.1M | -$633.0K | ||
| Nonoperating Income Expense | $1.9M | $1.8M | $1.2M | $1.7M | $12.0K | $2.0M | $1.8M | $1.4M | $1.5M | $390.0K | -$519.0K | -$716.0K | -$333.0K | -$908.0K | -$25.0K | $4.0K | $13.0K | $161.0K | -$48.0K | ||
| Comprehensive Income Net Of Tax | -$12.3M | -$20.4M | -$25.2M | -$22.9M | -$33.4M | -$35.8M | -$39.1M | -$31.4M | -$23.4M | -$22.5M | -$5.7M | -$20.2M | -$15.7M | $6.3M | $10.4M | -$10.1M | -$3.3M | -$2.0M | -$681.0K | ||
| Other Nonoperating Income Expense | $98.0K | -$145.0K | -$81.0K | $67.0K | -$65.0K | -$181.0K | -$48.0K | -$47.0K | $6.0K | -$7.0K | $106.0K | $37.0K | $5.0K | -$39.0K | -$34.0K | $0.00 | $0.00 | $0.00 | |||
| Revenues | $118.7M | $102.7M | $78.3M | $48.1M | $40.8M | $27.6M | $1.9M | $0.00 | $2.5M | $0.00 | $15.3M | $539.0K | $1.2M | $22.0M | $33.4M | $0.00 | $0.00 | $0.00 | |||
| General And Administrative Expense | $57.9M | $58.8M | $51.6M | $30.3M | $20.3M | $15.1M | $12.0M | $10.4M | $7.9M | $6.7M | $6.8M | $5.2M | $2.2M | $1.5M | $606.0K | $234.0K | |||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$5.0K | $0.00 | $1.0K | -$341.0K | $29.0K | $313.0K | $1.0K | $0.00 | $0.00 | $0.00 | ||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $250.0K | -$46.0K | -$94.0K | $522.0K | -$113.0K | -$61.0K | $15.0K | $47.0K | $4.0K | -$10.0K | $0.00 | $0.00 | $0.00 | ||||||||
| Other Comprehensive Income Loss Net Of Tax | $250.0K | -$46.0K | -$94.0K | $522.0K | -$113.0K | -$61.0K | $15.0K | $47.0K | $4.0K | ||||||||||||
| Amortization Of Intangible Assets | $200.0K | $200.0K | $240.0K | $100.0K | $100.0K | $100.0K | $0.00 | $0.00 | $0.00 | ||||||||||||
| Operating Expenses | $20.5M | $20.1M | $16.9M | $14.7M | $22.7M | $10.1M | $3.3M | $2.1M | $633.0K | ||||||||||||
| Cost Of Goods And Services Sold | $0.00 | $0.00 | $0.00 | $522.0K | $33.0K | $65.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $343.4M | $224.5M | $197.0M | $192.9M | $166.7M | $166.0M | -$6.0M | -$1.4M | -$44.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $186.2M | $97.4M | $224.9M | $71.7M | $171.3M | $168.1M | $58.0M | $2.4M | |
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $63.4M | $3.6M | $0.00 | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $10.2M | $384.0K | $1.8M | $0.00 | $741.0K | $726.0K | $163.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $88.8M | -$127.6M | $153.3M | -$99.7M | $3.2M | $110.2M | $55.6M | ||
| Operating Lease Right Of Use Asset | $10.1M | $552.0K | $1.9M | $575.0K | $1.1M | $688.0K | $126.0K | ||
| Retained Earnings Accumulated Deficit | -$426.6M | -$360.2M | -$244.7M | -$108.8M | -$46.7M | -$32.8M | -$6.0M | ||
| Property Plant And Equipment Net | $11.7M | $2.3M | $1.5M | $957.0K | $755.0K | $548.0K | $154.0K | ||
| Other Receivables Net Current | $2.1M | $1.3M | $1.1M | $3.6M | $92.0K | $20.0K | $36.0K | ||
| Other Assets Noncurrent | $1.9M | $999.0K | $1.5M | $585.0K | $1.1M | $81.0K | $6.0K | ||
| Liabilities Current | $135.7M | $80.6M | $36.9M | $15.4M | $11.5M | $5.4M | $819.0K | ||
| Liabilities And Stockholders Equity | $562.2M | $377.0M | $265.5M | $227.9M | $178.9M | $172.0M | $58.3M | ||
| Liabilities | $218.7M | $152.5M | $68.5M | $35.0M | $12.2M | $6.0M | $919.0K | ||
| Employee Related Liabilities Current | $17.8M | $15.8M | $13.2M | $5.5M | $2.8M | $1.0M | $299.0K | ||
| Common Stock Value | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | $2.0K | ||
| Assets Current | $522.8M | $356.7M | $256.1M | $225.4M | $176.0M | $170.7M | $58.0M | ||
| Assets | $562.2M | $377.0M | $265.5M | $227.9M | $178.9M | $172.0M | $58.3M | ||
| Accounts Payable And Other Accrued Liabilities Current | $101.5M | $55.4M | $23.7M | $9.9M | $8.7M | $4.3M | $520.0K | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Other Liabilities Noncurrent | $10.6M | $0.00 | $1.7M | $100.0K | $699.0K | $605.0K | $100.0K | ||
| Marketable Securities Current | $233.6M | $196.6M | $2.5M | $145.4M | $483.0K | $0.00 | |||
| Operating Lease Noncash Expense | $682.0K | $635.0K | $541.0K | $464.0K | |||||
| Long Term Debt Noncurrent | $72.4M | $71.8M | $29.8M | $19.4M | $0.00 | ||||
| Accounts Receivable Net Current | $85.1M | $46.8M | $16.6M | $0.00 | |||||
| Long Term Investments | $3.9M | $3.0M | $631.0K | $371.0K | $0.00 | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $5.5M | $4.2M | $3.2M | $1.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $335.1M | $332.6M | $342.5M | $237.5M | $252.2M | $275.2M | $213.7M | $147.7M | $173.4M | $202.6M | $221.5M | $149.2M | $179.1M | $192.5M | $183.2M | -$17.8M | -$11.0M | -$8.0M | -$4.6M | -$3.9M | -$3.1M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $115.3M | $99.2M | $178.4M | $176.2M | $181.1M | $193.7M | $226.7M | $106.8M | $66.0M | $169.5M | $245.4M | $175.0M | $183.8M | $176.7M | $156.2M | $86.3M | $53.2M | $55.9M | $357.0K | |||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $103.2M | $63.4M | $63.4M | $3.6M | $3.6M | $3.6M | |||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $384.0K | $116.0K | $0.00 | $600.0K | |||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $81.0M | -$31.2M | -$5.7M | $3.7M | -$12.0M | -$2.1M | ||||||||||||||||||
| Operating Lease Right Of Use Asset | $10.2M | $229.0K | $393.0K | $1.8M | $2.0M | $2.1M | $2.0M | $2.1M | $540.0K | $696.0K | $813.0K | $926.0K | $1.2M | $540.0K | $584.0K | $759.0K | ||||||||
| Retained Earnings Accumulated Deficit | -$418.3M | -$405.7M | -$385.3M | -$337.1M | -$313.7M | -$280.4M | -$202.8M | -$163.6M | -$132.2M | -$95.2M | -$72.7M | -$66.9M | -$31.8M | -$16.1M | -$22.5M | -$21.4M | ||||||||
| Property Plant And Equipment Net | $5.7M | $3.2M | $2.8M | $2.4M | $2.2M | $1.3M | $1.6M | $1.5M | $1.2M | $951.0K | $963.0K | $915.0K | $519.0K | $481.0K | $589.0K | $604.0K | ||||||||
| Other Receivables Net Current | $1.7M | $1.9M | $1.7M | $1.1M | $1.3M | $1.5M | $1.0M | $246.0K | $418.0K | $4.0M | $603.0K | $306.0K | $139.0K | $157.0K | $247.0K | $1.0K | ||||||||
| Other Assets Noncurrent | $1.2M | $1.2M | $616.0K | $888.0K | $846.0K | $1.3M | $1.3M | $1.5M | $529.0K | $583.0K | $600.0K | $887.0K | $1.6M | $1.5M | $1.3M | $1.8M | ||||||||
| Liabilities Current | $117.1M | $90.3M | $86.3M | $65.9M | $51.6M | $42.5M | $23.2M | $14.8M | $13.3M | $14.3M | $11.7M | $12.6M | $10.4M | $10.5M | $10.1M | $6.1M | ||||||||
| Liabilities And Stockholders Equity | $534.6M | $495.0M | $500.8M | $376.3M | $376.8M | $349.3M | $268.3M | $188.9M | $211.2M | $236.5M | $252.8M | $181.5M | $190.4M | $203.5M | $194.0M | $92.2M | ||||||||
| Liabilities | $199.5M | $162.4M | $158.3M | $138.8M | $124.6M | $74.1M | $54.7M | $41.2M | $37.8M | $33.8M | $31.3M | $32.3M | $11.3M | $11.0M | $10.7M | $6.9M | ||||||||
| Employee Related Liabilities Current | $13.6M | $11.6M | $9.9M | $11.3M | $8.0M | $6.0M | $7.9M | $5.3M | $4.2M | $4.1M | $2.8M | $1.8M | $2.2M | $1.5M | $685.0K | $520.0K | ||||||||
| Common Stock Value | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | ||||||||
| Assets Current | $501.7M | $474.4M | $480.8M | $357.1M | $362.6M | $340.7M | $259.3M | $183.5M | $208.6M | $234.1M | $250.3M | $178.8M | $187.1M | $200.9M | $191.5M | $89.1M | ||||||||
| Assets | $534.6M | $495.0M | $500.8M | $376.3M | $376.8M | $349.3M | $268.3M | $188.9M | $211.2M | $236.5M | $252.8M | $181.5M | $190.4M | $203.5M | $194.0M | $92.2M | ||||||||
| Accounts Payable And Other Accrued Liabilities Current | $103.5M | $78.6M | $76.4M | $54.5M | $43.5M | $36.6M | $15.4M | $9.5M | $9.0M | $10.2M | $8.9M | $10.8M | $8.1M | $9.0M | $9.4M | $5.6M | ||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Other Liabilities Noncurrent | $10.1M | $1.2M | $1.4M | $1.6M | $1.7M | $1.8M | $40.0K | $209.0K | $343.0K | $496.0K | $905.0K | $524.0K | $604.0K | $711.0K | ||||||||||
| Marketable Securities Current | $289.1M | $284.5M | $232.1M | $140.7M | $142.5M | $104.8M | $20.2M | $71.5M | $135.2M | $57.1M | $0.00 | $291.0K | ||||||||||||
| Operating Lease Noncash Expense | $164.0K | $132.0K | $151.0K | $113.0K | $43.0K | |||||||||||||||||||
| Long Term Debt Noncurrent | $72.3M | $72.1M | $72.0M | $71.7M | $71.6M | $29.9M | $29.7M | $24.6M | $24.5M | $19.4M | $19.3M | $19.2M | ||||||||||||
| Accounts Receivable Net Current | $72.6M | $58.3M | $62.4M | $29.2M | $29.5M | $29.9M | $5.4M | $2.5M | $17.0K | $17.0K | $17.0K | $0.00 | $20.0M | $25.0M | $0.00 | |||||||||
| Long Term Investments | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $0.00 | $210.0K | $322.0K | $306.0K | $157.0K | $169.0K | |||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.3M | $290.0K | $1.5M | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $41.7M | $27.8M | $19.8M | $13.5M | $8.5M | $839.0K | $18.0K |
| Payments To Acquire Property Plant And Equipment | $9.9M | $1.6M | $1.5M | $506.0K | $586.0K | $456.0K | $175.0K |
| Net Cash Provided By Used In Operating Activities | -$12.5M | -$83.0M | -$117.5M | -$49.0M | $3.7M | -$21.1M | -$3.7M |
| Net Cash Provided By Used In Investing Activities | -$42.1M | -$199.2M | $140.6M | -$144.6M | -$586.0K | -$456.0K | -$175.0K |
| Net Cash Provided By Used In Financing Activities | $143.4M | $154.7M | $130.2M | $94.0M | $21.0K | $131.8M | $59.4M |
| Increase Decrease In Other Receivables | $754.0K | $206.0K | -$2.5M | $3.5M | $73.0K | -$16.0K | $32.0K |
| Increase Decrease In Other Noncurrent Assets | $527.0K | -$572.0K | $718.0K | $215.0K | $2.3M | $75.0K | $6.0K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $6.9M | $2.5M | $4.5M | $821.0K | $3.9M | $3.2M | $245.0K |
| Increase Decrease In Employee Related Liabilities | $2.0M | $2.6M | $7.7M | $2.7M | $1.8M | $741.0K | $296.0K |
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | -$233.0K | $185.0K | -$67.0K | $115.0K | $0.00 | |
| Increase Decrease In Accounts Receivable | $38.3M | $30.1M | $16.6M | $0.00 | |||
| Payments Of Stock Issuance Costs | $9.0M | $6.7M | $6.9M | $5.3M | $2.4M | ||
| Payments To Acquire Available For Sale Securities Debt | $393.2M | $262.6M | $28.7M | $149.4M | $0.00 | ||
| Payments Of Debt Issuance Costs | $0.00 | $3.5M | $0.00 | $875.0K | $0.00 | ||
| Proceeds From Issuance Of Long Term Debt | $0.00 | $75.0M | $10.0M | $20.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q1 2023 | Q2 2022 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $6.9M | $5.5M | $3.9M | $2.7M | $1.4M | $4.0K | ||
| Payments To Acquire Property Plant And Equipment | $590.0K | $174.0K | $340.0K | $161.0K | $175.0K | $36.0K | ||
| Net Cash Provided By Used In Operating Activities | -$20.7M | -$37.8M | -$22.0M | -$15.3M | -$11.8M | -$2.0M | ||
| Net Cash Provided By Used In Investing Activities | -$34.9M | -$102.2M | $11.3M | -$161.0K | -$175.0K | -$36.0K | ||
| Net Cash Provided By Used In Financing Activities | $136.6M | $108.8M | $5.0M | $19.1M | $19.0K | -$27.0K | ||
| Increase Decrease In Other Receivables | $429.0K | $383.0K | -$3.2M | $225.0K | $227.0K | -$4.0K | ||
| Increase Decrease In Other Noncurrent Assets | -$125.0K | -$106.0K | -$38.0K | -$14.0K | $1.3M | $0.00 | ||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $11.3M | $12.3M | -$1.0M | $2.0M | $5.1M | $313.0K | ||
| Increase Decrease In Employee Related Liabilities | -$5.9M | -$7.3M | -$1.3M | -$993.0K | -$355.0K | -$165.0K | ||
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | -$232.0K | -$8.0K | -$43.0K | $123.0K | $0.00 | ||
| Increase Decrease In Accounts Receivable | $15.7M | $13.3M | $2.5M | $17.0K | $25.0M | $0.00 | ||
| Payments Of Stock Issuance Costs | $9.0M | $6.7M | $6.9M | $5.2M | $0.00 | $27.0K | ||
| Payments To Acquire Available For Sale Securities Debt | $125.6M | $104.6M | $28.7M | $0.00 | ||||
| Payments Of Debt Issuance Costs | $0.00 | $815.0K | $0.00 | |||||
| Proceeds From Issuance Of Long Term Debt | $0.00 | $5.0M | $20.0M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.59 | -$3.07 | -$4.62 | -$2.52 | -$0.67 | -$4.32 | -$1.98 | ||
| Weighted Average Number Of Shares Outstanding Basic | 41.8M | 37.6M | 29.4M | 24.6M | 20.6M | 6.2M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 41.8M | 37.6M | 29.4M | 24.6M | 20.6M | 6.2M | |||
| Temporary Equity Shares Outstanding | 0.00 | 8.2M | 1.6M | 0.00 | |||||
| Earnings Per Share Basic | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | ||
| Common Stock Shares Outstanding | 42.6M | 38.3M | 34.2M | 26.7M | 20.7M | 20.3M | 2.6M | ||
| Common Stock Shares Issued | 42.6M | 38.3M | 34.2M | 26.7M | 20.7M | 20.5M | 2.7M | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.30 | -$0.48 | -$0.64 | -$0.61 | -$0.88 | -$1.01 | -$1.28 | -$1.17 | -$0.88 | -$0.84 | -$0.24 | -$0.98 | -$0.76 | $0.29 | $0.47 | -$3.71 | -$1.23 | -$0.74 | -$0.28 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 42.6M | 42.4M | 39.3M | 38.4M | 37.8M | 35.3M | 30.6M | 26.8M | 26.7M | 26.7M | 24.3M | 20.7M | 20.6M | 20.6M | 20.3M | 2.7M | 2.7M | 2.7M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 42.6M | 42.4M | 39.3M | 38.4M | 37.8M | 35.3M | 30.6M | 26.8M | 26.7M | 26.7M | 24.3M | 20.7M | 20.6M | 22.0M | 21.8M | 2.7M | 2.7M | 2.7M | ||||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.1M | 8.2M | 8.2M | 1.6M | 1.6M | 1.6M | |||||||
| Earnings Per Share Basic | $-0.30 | $-0.48 | $-0.64 | $-0.61 | $-0.88 | $-1.01 | $-1.28 | $-1.17 | $-0.88 | $-0.84 | $-0.24 | $-0.98 | $-0.76 | $0.31 | $-0.51 | $-3.71 | $-1.23 | $-0.74 | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 17.5M | 17.5M | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||
| Common Stock Shares Outstanding | 42.4M | 42.2M | 42.0M | 38.2M | 38.0M | 37.7M | 33.1M | 26.9M | 26.8M | 26.7M | 26.6M | 20.7M | 20.7M | 20.6M | 20.5M | 2.9M | ||||||||
| Common Stock Shares Issued | 42.4M | 42.2M | 42.0M | 38.2M | 38.0M | 37.7M | 33.1M | 26.9M | 26.8M | 26.7M | 26.7M | 20.7M | 20.7M | 20.7M | 20.7M | 3.1M | ||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $41.7M | $27.8M | $19.8M | $13.5M | $8.5M | $839.0K | $18.0K | $9.0K |
| Stock Issued During Period Value Stock Options Exercised | $6.3M | $5.6M | $592.0K | $123.0K | $103.0K | $10.0K | ||
| Embedded Derivative Gain Loss On Embedded Derivative Net | $0.00 | -$201.0K | $117.0K | -$501.0K | -$987.0K | $0.00 | -$76.0K | |
| Additional Paid In Capital | $769.7M | $584.6M | $441.6M | $301.7M | $213.4M | $198.8M | $27.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $1.5M | $99.0K | $134.0K | $21.0K | $2.0K | $34.0K | $10.0K | |
| Interest Income Other | $15.7M | $15.0M | $10.3M | $3.5M | ||||
| Costs And Expenses | $522.3M | $303.5M | $160.6M | $88.5M | ||||
| Interest Paid Net | $8.3M | $7.7M | $2.9M | $1.7M | $0.00 | |||
| Foreign Currency Transaction Gain Loss Unrealized | $0.00 | -$1.0K | $2.0K | $0.00 | ||||
| Amortization Of Financing Costs And Discounts | $593.0K | $482.0K | $385.0K | $309.0K | $0.00 | |||
| Depreciation | $855.0K | $685.0K | $744.0K | $326.0K | ||||
| Prepaid Expense Current | $13.5M | $14.7M | $7.9M | $4.8M | $4.0M | $2.5M | $22.0K | |
| Stock Issued During Period Value New Issues | $134.8M | $98.3M | $99.3M | $74.2M | $91.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $12.2M | $8.2M | $6.9M | $7.4M | $7.5M | $5.5M | $5.3M | $5.2M | $3.9M | $3.6M | $3.5M | $2.7M | $2.1M | $2.8M | $1.4M | $223.0K | $173.0K | $4.0K | $5.0K | $5.0K | $4.0K |
| Stock Issued During Period Value Stock Options Exercised | $2.6M | $1.2M | $1.4M | $721.0K | $1.8M | $802.0K | $516.0K | $45.0K | $13.0K | $82.0K | $17.0K | $174.0K | $1.0K | $19.0K | $6.0K | ||||||
| Embedded Derivative Gain Loss On Embedded Derivative Net | $0.00 | $0.00 | $0.00 | -$201.0K | -$36.0K | $18.0K | -$17.0K | -$18.0K | -$257.0K | -$245.0K | -$346.0K | -$876.0K | $0.00 | $0.00 | $0.00 | -$27.0K | |||||
| Additional Paid In Capital | $753.0M | $738.2M | $727.7M | $574.2M | $566.1M | $555.7M | $416.4M | $311.4M | $305.7M | $297.8M | $294.2M | $216.1M | $211.0M | $208.6M | $205.7M | $3.5M | |||||
| Capital Expenditures Incurred But Not Yet Paid | $39.0K | $0.00 | $0.00 | $41.0K | $0.00 | $12.0K | |||||||||||||||
| Interest Income Other | $4.1M | $4.2M | $3.5M | $4.1M | $4.1M | $3.1M | $2.8M | $2.2M | $2.3M | $1.1M | $297.0K | $0.00 | $8.0K | ||||||||
| Costs And Expenses | $133.2M | $124.8M | $104.6M | $73.3M | $74.1M | $65.3M | $42.8M | $32.8M | $27.5M | $22.9M | $20.5M | $20.1M | $16.9M | ||||||||
| Interest Paid Net | $2.1M | $868.0K | $593.0K | $127.0K | $0.00 | ||||||||||||||||
| Foreign Currency Transaction Gain Loss Unrealized | $0.00 | -$16.0K | -$1.0K | $35.0K | $0.00 | ||||||||||||||||
| Amortization Of Financing Costs And Discounts | $139.0K | $114.0K | $81.0K | $55.0K | $0.00 | ||||||||||||||||
| Depreciation | $200.0K | $200.0K | $220.0K | $200.0K | $100.0K | $170.0K | $200.0K | $200.0K | $104.0K | $100.0K | |||||||||||
| Prepaid Expense Current | $21.7M | $29.2M | $6.0M | $7.0M | $6.0M | $6.8M | $6.0M | $5.0M | $4.5M | $3.5M | |||||||||||
| Stock Issued During Period Value New Issues | $134.8M | $3.0K | $98.3M | $99.3M | $74.3M |
Most recent annual filing with the SEC: February 23, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.